BTLN · Glimpse Group, Inc.

This option vests in equal monthly installments over a one-year period commencing on the grant date.

This option vests in equal monthly installments over a one-year period commencing on the grant date.

This option vests in equal monthly installments over a one-year period commencing on the grant date.

This option vests in equal monthly installments over a one-year period commencing on the grant date.

This option vested immediately upon grant.

This option vested immediately upon grant.

Perimetre Capital, LLC is an entity owned and managed by Mr. Enslin.

This option vests with respect to 60,422 shares on 5/31/2026, then vests in equal monthly increments from 6/30/2026 through 12/31/2026.

This option vested immediately upon grant.

Reflects common stock acquired by the Reporting person on December 18, 2025

Represents the average purchase price for the Company's shares.

This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.

This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.

This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.

Perimetre Capital, LLC is an entity owned and managed by Mr. Enslin.

This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.

This option vests in equal monthly increments from 1/31/2025 through 12/31/2025.

Reflects common stock acquired by the Reporting person on December 11, 2024

Represents the average purchase price for the Company's shares.

Reflects common stock acquired by the Reporting person.

Reflects common stock acquired by the Reporting person.

Reflects common stock acquired by the Reporting person.

Reflects common stock acquired by the Reporting person.

On April 27, 2024, the board of directors (the "Board") of The Glimpse Group, Inc. (the "Company"), appointed Dr. Elkeles to the Board, and in connection therewith, agreed to grant to Dr Elkeles, under the Company's 2016 Incentive Plan, options ("Options") to purchase an aggregate of 20,000 shares of the Company's common stock, as compensation for her service on the Board for the remainder of the calendar year ending December 31, 2024. The Options vest in monthly increments beginning April 29, 2024 through December 31, 2024, and are exercisable for $2.50 per share. The Options are deemed exercisable when, and to the extent, they become vested.

Represents options to purchase 24,000 shares of the issuer's common stock granted to Mr. Charles on March 1, 2024, as director compensation for calendar year 2024. The options vest monthly in arrears, retroactive to January 1, 2024 with an exercise price of $2.50 per share. These options are set to expire 10 years from grant date.

Mr. Charles was granted options to purchase 20,475 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, which options became exercisable upon grant with an exercise price of $2.50 per share. These options are set to expire seven years from grant date.

Represents 25,000 shares of the issuer's common stock granted to Mr. Ruckdaeschel on March 1, 2024, as director compensation for calendar year 2024.

Represents 25,000 shares of the issuer's common stock granted to Mr. Enslin on March 1, 2024, as director compensation for calendar year 2024.

The 243,631 shares shown as beneficially owned does not include 102,149 shares of common stock indirectly held by Mr. Enslin, through Perimetre Capital, LLC, an entity owned and managed by Mr. Enslin. Of the 243,631 shares of common stock shown as beneficially owned following the reported transactions, Mr. Enslin directly owns 3,000 shares. The remaining 240,631 shares are indirectly held by Mr. Ensin through Perimetre Capital, LLC.

Mr. Smith was granted options to purchase an aggregate of 51,480 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 17,160 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 17,160 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 17,160 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date.

Represents 215,631 shares of the issuer's common stock granted to Mr. Enslin on March 1, 2024.

The 243,631 shares shown as beneficially owned does not include 102,149 shares of common stock indirectly held by Mr. Enslin, through Perimetre Capital, LLC, an entity owned and managed by Mr. Enslin. Of the 243,631 shares of common stock shown as beneficially owned following the reported transactions, Mr. Enslin directly owns 3,000 shares. The remaining 240,631 shares are indirectly held by Mr. Ensin through Perimetre Capital, LLC.

Represents 18,889 shares of the issuer's common stock granted to Mr. Ruckdaeschel on March 1, 2024.

Mr. Gates was granted options to purchase an aggregate of 5,532 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 1,844 shares of the issuer's common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 1,844 shares of the issuer's common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 1,844 shares of the issuer's common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date.

Represents 25,000 shares of the issuer's common stock granted to Mr. Amen on March 1, 2024, as director compensation for calendar year 2024.

Mr. Bentovim was granted options to purchase an aggregate of 72,153 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 24,051 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date.

Mr. Rothblum was granted options to purchase an aggregate of 306,145 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 18,715 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 18,715 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, (iii) options to purchase 18,715 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027, and (iv) options to purchase 250,000 shares of common stock, at an exercise price of $1.50 per share, which vest monthly over 45 months. All of the foregoing options, other than the option to purchase 250,000 shares of common stock, expire seven years from the grant date. The option to purchase 250,000 shares of common stock expires ten years from the grant date.

Represents 23,122 shares of the issuer's common stock granted to Mr. Amen on March 1, 2024.

Represents the forfeiture, by Mr. Ruckdaeschel, of fully vested options to purchase an aggregate of 37,778 shares of the issuer's common stock granted under the issuer's 2016 equity incentive plan (the "2016 Plan"), as amended, consisting of (i) options to purchase 5,886 shares of the issuer's common stock granted to Mr. Ruckdaeschel on July 16, 2021 with an exercise price of $9.13 per share, (ii) options to purchase 11,892 shares of the issuer's common stock granted to Mr. Ruckdaeschel on January 1, 2022 with an exercise price of $10.20 per share, and (iii) options to purchase 20,000 shares of the issuer's common stock granted to Mr. Ruckdaeschel on February 27, 2023 with an exercise price of $5.00 per share. The foregoing options were to expire 10 years from their respective grant dates.

Represents the forfeiture of fully vested options to purchase an aggregate of 320,180 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 25,008 shares of common stock and 8,328 shares of common stock granted on September 1, 2019 and September 1, 2020, respectively, with an exercise price of $4.00/share, (ii) 33,333 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share, (iii) 8 shares of common stock and 3 shares of common stock granted on September 1, 2020 and January 1, 2021, respectively, with exercise prices of $4.00/share and $4.50 /share, respectively, (iv) 2,333 shares of common stock and 1,167 shares of common stock granted on July 1, 2020 and August 1, 2020, with an exercise price of $4.50/share, and (v) 250,000 shares of common stock granted on June 20, 2017, with an exercise price of $2.50.

The options in footnote (1) were to expire 10 years from their respective grant dates.

Represents the forfeiture, by Mr. Amen, of fully vested options to purchase an aggregate of 46,244 shares of the issuer's common stock granted under the issuer's 2016 equity incentive plan, as amended, consisting of (i) options to purchase 14,352 shares of the issuer's common stock granted to Mr. Amen on May 1, 2021 with an exercise price of $5.00 per share, (ii) options to purchase 11,892 shares of the issuer's common stock granted to Mr. Amen on January 1, 2022 with an exercise price of $10.20 per share, and (iii) options to purchase 20,000 shares of the issuer's common stock granted to Mr. Amen on February 27, 2023 with an exercise price of $5.00 per share. The foregoing options were to expire 10 years from their respective grant dates.

Represents the forfeiture, by Mr. Gates, of fully vested options to purchase an aggregate of 9,216 shares of the issuer's common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of (i) options to purchase 4,608 shares of the issuer's common stock granted to Mr. Gates on January 6, 2023 with an exercise price of $7.00 per share, and (ii) options to purchase 4,608 shares of the issuer's common stock granted to Mr. Gates on April 1, 2023 with an exercise price of $7.00 per share. The foregoing options were to expire 10 years from their respective grant dates.

Represents the forfeiture of vested options to purchase an aggregate of 64,349 shares of common stock ("CS") granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 4,500 shares of CS and 20,004 shares of CS granted on January 6, 2023 and September 1, 2018, respectively, with exercise prices of $7.00/share and $4.00/share, respectively, (ii) 6,668 shares of CS and 14,232 shares of CS granted on September 1, 2019 and January 1, 2020, respectively, with exercise prices of $4.00/share and $4.50/share, respectively, (iii) 1,333 shares of CS and 667 shares of CS granted on May 1, 2020 and July 1, 2020, respectively, with an exercise price of $4.50/share, (iv) 889 shares of CS and 11,556 shares of CS granted on November 1, 2020 and January 1, 2021, with an exercise price of $4.50/share, and (v) 4,500 shares of CS granted on April 1, 2023 with an exercise price of $7.00/share.

The options in footnote (1) were to expire 10 years from their respective grant dates.

Represents the forfeiture, by Mr. Charles, of fully vested options to purchase an aggregate of 30,560 shares of the issuer's common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of (i) options to purchase 10,560 shares of the issuer's common stock granted to Mr. Charles on January 13, 2022 with an exercise price of $10.09 per share, and (ii) options to purchase 20,000 shares of the issuer's common stock granted to Mr. Charles on February 27, 2023 with an exercise price of $5.00 per share. The foregoing options were to expire 10 years from their respective grant dates.

Represents the forfeiture of fully vested options to purchase an aggregate of 90,188 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 32,508 shares of common stock granted on August 1, 2018 with an exercise price of $4.00/share, (ii) 6,037 shares of common stock and 4,799 shares of common stock granted on September 1, 2019 with an exercise price of $4.00/share, (iii) 22,222 shares of common stock and 6,674 shares of common stock granted on January 1, 2020 with an exercise price of $4.50/share, (iv) 2,333 shares of common stock granted on May 1, 2020 with an exercise price of $4.50/share, (v) 1,167 shares of common stock granted on July 1, 2020 with an exercise price of $4.50/share, and (vi) 14,448 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share.

The options in footnote (1) were to expire 10 years from their respective grant dates.

Represents the forfeiture of fully vested options to purchase an aggregate of 359,385 shares of the issuer's common stock, consisting of options to purchase (i) 19,833 shares of common stock granted on June 22, 2018 with an exercise price of $3.25/share, (ii) 5,210 shares of common stock granted on August 1, 2018 with an exercise price of $4.00/share, (iii) 25,008 shares of common stock granted on October 15, 2018 with an exercise price of $4.00/share, (iv) 225,000 shares of common stock granted on March 8, 2019 with an exercise price of $4.00/share, (v) 30,218 shares of common stock granted on October 15, 2019 with an exercise price of $4.00/share, (vi) 22,224 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share, (vii) 11,892 shares of common stock granted on January 1, 2022 with an exercise price of $10.20/share, and (viii) 20,000 shares of common stock granted on February 27, 2023 with an exercise price of $5.00/share.

The newly granted option to purchase 250,000 shares of common stock at an exercise price of $2.50 is subject to a 75 month vesting schedule of 3,333 shares per month for 74 months (with the first vest occurring on October 29, 2023), and 3,358 vesting on the final month.

The direct beneficial ownership set forth above does not include 3,528 shares indirectly held by Mr. Rothblum (through Mr. Rothblum's mother, Naomi Rothblum) and does not include: (i) 486,450 shares of common stock held by Mr. Rothblum; (ii) 70,180 fully-vested options to purchase common stock held by Mr. Rothblum; and (iii) 770,000 options to purchase common stock into which Mr. Rothblum may vest upon achieving certain performance milestones.

On September 29, 2023, Mr. Rothblum voluntarily cancelled a previously issued stock option dated June 20, 2017, which cancelled a fully-vested option to purchase 250,000 shares of common stock with an exercise price of $2.50 per share.

On June 1, 2023, the Company, under its 2016 Incentive Plan, issued to Mr. Meisner options (the "Options") to purchase 120,000 shares of Common Stock, subject to the terms and conditions of Mr. Meisner's Options Agreement, which include certain provisions set for in the Remarks section below.

The beneficial ownership set forth above does not include (i) 232,902 shares directly held by Mr. Meisner.

The 62,500 shares of common stock were issued in an arms-length transaction pursuant to which the parties agreed to accelerate a potential earnout provision in an Amendment to the Membership Interest Sale Agreement dated May 25, 2023, between the Issuer and the sellers of Sector 5 Digital, LLC (S5D), of which Mr. Meisner was a membership interest holder at the time of the transaction. In connection with the accelerated earnout provision, Mr. Meisner received shares of the Issuer's common stock, instead of receiving a portion of the potential cash earnout payment due to him.

Reflects common stock granted by the Company, acquired by the Reporting person and issued by the Company to the Reporting Person, on April 3, 2023.

Represents the closing price for the Company's shares recorded on April 3, 2023.

Reflects common stock acquired by Mr. Meisner and issued by the Company to the Reporting Person, on April 1, 2023 in lieu of cash salary.

Reflects common stock acquired by Mr. Bentovim and issued by the Company on April 1, 2023 in lieu of cash salary.

Represents the closing price for the Company's shares recorded on April 1, 2023.

The direct beneficial ownership set forth above does not include 90,188 options to purchase common stock held by Mr. Bentovim. In addition, on February 15, 2023, the Company, under its 2016 Incentive Plan, issued to Mr. Bentovim options to purchase 1,210,000 shares of Common Stock, subject to the terms and conditions of Mr. Bentovim's Options Agreement, which include certain Company performance provisions.

On April 1, 2023, the Company, under its 2016 Incentive Plan, agreed to issue Mr. Smith options (the "Options") to purchase 4,500 shares of Common Stock in lieu of cash salary, which are fully vested upon issuance.

The beneficial ownership set forth above does not include the 59,849 options to purchase common stock already held by Mr. Smith. Furthermore, the ownership reflected herein does not include 250 shares directly held by Mr. Smith or 1,002,298 shares indirectly held by Mr. Smith (through VRTech Consulting LLC - an entity owned and managed by Mr. Smith). In addition, on February 15, 2023, the Company, under its 2016 Incentive Plan, issued to Mr. Smith options to purchase 220,000 shares of Common Stock, subject to the terms and conditions of Mr. Smith's Options Agreement, which includes certain Company performance provisions.